Frederick Pels

Mindbio Therapeutics, a subsidiary of cannabis and psychedelics holding company Blackhawk Growth Corp. (OTC: BLRZF), together with research collaborators at the University of Auckland, have received NZ$1.44 million ($650,000) in funding from New Zealand’s Health Research Council (...